drugset / Trial / NCT02815839
Single Dose Study of SHR4640 in Healthy Subjects
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The objective of the study is to assess the safety, tolerance, food effect, pharmacokinetic and pharmacodynamic properties of single dose adminstration of SHR4640 in healthy volunteers.
Timeline
- Start
- 2015-11
- Primary completion
- 2017-02
- Completion
- 2017-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SHR4640 | Small molecule | 2.5 mg | — |
| Subject | SHR4640 | Small molecule | 5 mg | — |
| Subject | SHR4640 | Small molecule | 7.5 mg | — |
| Subject | SHR4640 | Small molecule | 10 mg | — |
| Subject | SHR4640 | Small molecule | 20 mg | — |